Comparison between the Outcomes of Intracoronary and Intravenous Administration of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction.
CONCLUSIONS: IC administration of eptifibatide during PPCI in patients with STEMI in comparison with IV administration of eptifibatide is associated with significantly better coronary reperfusion and improved clinical outcomes (IRCT2012090510751N1).
PMID: 26632161 [PubMed - as supplied by publisher]
Source: Journal of Atherosclerosis and Thrombosis - Category: Cardiology Tags: J Atheroscler Thromb Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Clinical Trials | Coronary Angioplasty | Eptifibatide | Heart | Heart Attack | Integrilin | Percutaneous Coronary Intervention | Perfusion | Stroke | Thrombosis